MSLs Welcome to inVentiv Health You, our new knowledge director

Our Company

Shorten the distance between lab and life!

Here at inVentiv Health Selling Solutions, a critical segment of our Commercial Division, we offer innovative promotional and educational resources that deliver customized commercial solutions to the world’s leading healthcare companies so they can focus - on what they do best – prevent and treat disease.

The spirit of partnership is critical to success at inVentiv Health Selling Solutions. We integrate seamlessly with our clients and do what’s best for their success. We’re hungry for growth; ramping up our client-specific and therapeutic areas of expertise quickly. Our vast experience makes us some of the most talented professionals in the industry, but we check our egos at the door. Self-driven, we’re inspired by tackling challenges and taking ownership to ensure successful execution. We pride ourselves on our custom and creative solutions, requiring us to be flexible and adapt in our dynamic environment.

Clinical

The inVentiv Health Clinical Division is a leading provider of global drug development services to pharmaceutical, biotechnology, generic drug and medical device companies, offering therapeutically specialized capabilities for Phase I-IV clinical development, bioanalytical services and strategic resourcing from a single clinical professional to an entire functional team. With 7,000 passionate employees, the inVentiv Health Clinical Division works to accelerate high quality drug development programs of all sizes around the world.

Consulting

Campbell Alliance is a leading management consulting firm specializing in the pharmaceutical and biotech industry. Subsidiaries of Campbell Alliance include Market Research & Analytics and the Pharmaceutical Institute.

Commercial

The Commercial Division offers a unique broad range of services including consulting, sales teams and training, market access services, non-personal promotion, branding, advertising, public relations, adherence, medical affairs, field medical and nursing teams and full management of commercialization teams. Comprehensive commercialization provided through the Division's unique CCO offering integrates strategic, creative and operational expertise as never before to help clients optimize performance, reduce risk and expedite delivery of healthcare innovation to patients worldwide.

Our Project

Our customer is a leading globally engaged pharmaceutical company dedicated to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on the leading acute and intensive care hospitals worldwide

Effective postoperative pain control is an essential component of the care of the surgical patient. Inadequate pain control, apart from being inhumane, may result in increased morbidity or mortality (1)

Good analgesia can reduce this deleterious effect. Data available indicate that afferent neural blockade with local anesthetics is the most effective analgesic technique. Next in order of effectiveness are high-dose opioids, epidural opioids and clonidine, patient controlled opioid therapy, and nonsteroidal anti-inflammatory agents (1)

The product you are responsible for is an opioid-based patient controlled analgesic (PCA) therapy, one of the strongest growing areas in anaesthesia...

PCA allows the patient easier access to pain medication, reduced chance of medication error and ready titration, allowing the patient greater control over their treatment (2).

PCA can be used in any situation to manage severe pain once it is control e.g. acute pancreatitis, rib fractures or trauma awaiting surgery. (3)

PCA for postoperative pain control has been slowly supplanting conventional analgesia in most hospitals in both the USA and the rest of the western world. (4)

PCA has proven to be an important concept and therapeutic tool in the quest to improve acute pain management.[…] Because patients can control the amount of analgesia they receive, PCA can reduce their anxiety and the amount of opioid consumption they require, while still providing them with effective analgesia. (3)

Your Role

The MSL role has changed over the years. We want you to become our field based Knowledge Director; the scientific go-to-person for our KOLs and sales force, the person who ensures best practice share with KOLs; nationally and internationally, coordinates local trials and serves as our medical ambassador

And all this happens here:

In total we are looking for five MSLs to cover the UK, the Nordics (incl. the Netherlands) France and Germany (two territories). You will be our scientific voice into the KOL community in your assigned region.

As a MSL in this project you will drive the perception of our PCA system, will help the key players to understand the science behind the product and build a bridge between our medical department, our sales force and interested specialists. You will have the opportunity to design and run according initiatives on a national and European level and build a solid network within the respective target group.

Certainly you will receive a competitive salary plus bonus and additional benefits such as a company car or - optional - a car allowance.

Start date: As soon as you are available!

Interested in this opportunity? Here is the hiring process which we aim to keep as streamlined and efficient as possible:

1.) You send us your CV

2.) We contact you and run an interview via video

3.) We meet

4.) You will get the offer

Quotes:

(1): Sharrock NE, Cazan MG, Hargett MJ, Williams-Russo P, Wilson PD., Jr Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg. 1995;80:242–248 on http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317048/

(2): Bhavani-Shankar Kodali, Jasmeet S Oberoi, 2014. Management of postoperative pain. Accessed 05/08/2014

(3): Publication of Sailsbury NHS http://www.icid.salisbury.nhs.uk/ClinicalManagement/Pain/Pages/IVPatientcontrolledanalgesia.aspx#6_appendices

(4): Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain (Review) byHudcova J, McNicol ED, Quah CS, Lau J, Carr DB, p11 (http://clinicaldepartments.musc.edu/medicine/education/residency/acute%20pain%20hudcova.pdf)

Created By
Thomas Zadro
Appreciate

Made with Adobe Slate

Make your words and images move.

Get Slate

Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a Copyright Violation, please follow Section 17 in the Terms of Use.